Slingshot Insights | Eglt Overview

EGLT Overview

Upcoming Projects (EGLT)

Don’t see a project related to the company you care about? Create your own!

Upcoming & Overdue Catalysts (EGLT)

Don’t see a catalyst related to the company you care about? Create your own!

Occurred Catalysts (EGLT)

FDA to Review Egalet's (EGLT) Prior Approval Supplement (PAS) by June 17th for OXAYDO in Management of Acute and Chronic Moderate to Severe Pain
Ticker: EGLT
Occurred on: Apr 18, 2017
Egalet (EGLT) Plans U.S Commercial Launch of ARYMO ER C-II for Treatment of Chronic Pain in Q1 2017
Ticker: EGLT
Occurred on: Mar 30, 2017
FDA Approves Egalet's (EGLT) ARYMO ER C-II for Treatment of Chronic Pain
Ticker: EGLT
Occurred on: Jan 09, 2017
Egalet (EGLT) Awarded U.S Patent for Abuse-Deterrent Oxycodone Tablets, OXAYDO
Ticker: EGLT
Occurred on: Nov 17, 2016
FDA did not meet the PDUFA goal date for ARYMO ER (Morphine Sulfate) Extended-Release Tablets set for October 14, 2016. No news on the date the review will take place.
Ticker: EGLT
Occurred on: Nov 13, 2016
Egalet Announces FDA Advisory Committees Recommend Approval of Abuse-Deterrent ARYMO ER (Morphine Sulfate) and Reports Second Quarter 2016 Financial Results
Ticker: EGLT
Occurred on: Aug 04, 2016
Egalet Announces FDA Acceptance of New Drug Application for ARYMO ER (Morphine Sulfate) Extended-Release Tablets
Ticker: EGLT
Occurred on: Feb 29, 2016
Teva and Eagle Pharmaceuticals Announce Commercial Availability of BENDEKA (bendamustine hydrochloride) Injection
Tickers: TEVA, EGLT
Occurred on: Jan 28, 2016

Strategic Initiatives (EGLT)

Egalet (EGLT) and Septodont Reach Collaboration Deal to Promote SPRIX Nasal Spray to U.S Dentists
Tickers: EGLT, Septodont
Announcement Date: Feb 08, 2016